CIK 0001621221 · Non-accelerated filer<br>Smaller reporting company
ARTELO BIOSCIENCES, INC.
Sign in to watch- Ticker
- ARTL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 331220924
- Phone
- 858-925-7049
- Business address
- 505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA, 92075
- Former names
- REACTIVE MEDICAL INC., KNIGHT KNOX DEVELOPMENT CORP.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-28 | EMANUELE ROBERT MARTIN Director | Grant or award · Stock Option (right to buy) | +1,083 | 1,083 | ||
| 2024-02-28 | Kelly Steven Director | Returned to the company · Stock Option (right to buy) | −1,484 | 0 | ||
| 2024-02-28 | Kelly Steven Director | Returned to the company · Stock Option (right to buy) | −9,634 | 0 | ||
| 2024-02-28 | Kelly Steven Director | Returned to the company · Stock Option (right to buy) | −667 | 0 | ||
| 2024-02-28 | Kelly Steven Director | Returned to the company · Stock Option (right to buy) | −667 | 0 | ||
| 2024-02-28 | Kelly Steven Director | Returned to the company · Stock Option (right to buy) | −667 | 0 | ||
| 2024-02-28 | Kelly Steven Director | Returned to the company · Stock Option (right to buy) | −1,083 | 0 | ||
| 2024-02-28 | Kelly Steven Director | Grant or award · Stock Option (right to buy) | +1,484 | 1,484 | ||
| 2024-02-28 | Kelly Steven Director | Grant or award · Stock Option (right to buy) | +9,634 | 9,634 | ||
| 2024-02-28 | Kelly Steven Director | Grant or award · Stock Option (right to buy) | +667 | 667 | ||
| 2024-02-28 | Kelly Steven Director | Grant or award · Stock Option (right to buy) | +667 | 667 | ||
| 2024-02-28 | Kelly Steven Director | Grant or award · Stock Option (right to buy) | +667 | 667 | ||
| 2024-02-28 | Kelly Steven Director | Grant or award · Stock Option (right to buy) | +1,083 | 1,083 | ||
| 2024-02-28 | Gorgas Gregory D. Pres, CEO, CFO, Treas & Sec | Returned to the company · Stock Option (right to buy) | −5,000 | 0 | ||
| 2024-02-28 | Gorgas Gregory D. Pres, CEO, CFO, Treas & Sec | Returned to the company · Stock Option (right to buy) | −55,634 | 0 | ||
| 2024-02-28 | Gorgas Gregory D. Pres, CEO, CFO, Treas & Sec | Returned to the company · Stock Option (right to buy) | −38,340 | 0 | ||
| 2024-02-28 | Gorgas Gregory D. Pres, CEO, CFO, Treas & Sec | Returned to the company · Stock Option (right to buy) | −90,334 | 0 | ||
| 2024-02-28 | Gorgas Gregory D. Pres, CEO, CFO, Treas & Sec | Returned to the company · Stock Option (right to buy) | −85,000 | 0 | ||
| 2024-02-28 | Gorgas Gregory D. Pres, CEO, CFO, Treas & Sec | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2024-02-28 | Gorgas Gregory D. Pres, CEO, CFO, Treas & Sec | Grant or award · Stock Option (right to buy) | +55,634 | 55,634 |
Page 4 of 9 · 176 trades